Skip to main content

Table 3 Study-specific actions a

From: The INCA trial (Impact of NOD2 genotype-guided antibiotic prevention on survival in patients with liver Cirrhosis and Ascites): study protocol for a randomized controlled trial

Action

Baseline period

Study visits

Telephone visits

Informed consent

X

  

Checking inclusion and exclusion criteria

X

  

Demographics

X

  

Medical history (with focus on liver disease)

X

  

NOD2 genetic testing

X

  

Concomitant diseases

X

X

X

Concomitant medications

X

X

X

MELD and Child-Pugh-scores

X

X

 

Clinical assessment and vital signs

X

X

 

12-lead ECG

X

X

 

Blood tests (safety parameters)

X

X

 

Recording of adverse events

 

X

X

Distribution and return of study medication

 

X

 

Collection of ascites samples (clinically indicated puncture)

X

X

 

Collection of stool samples

 

X

 
  1. aECG, Electrocardiography; MELD, Model For End-Stage Liver Disease.